Please login to the form below

Not currently logged in
Email:
Password:

Judges

Richard Bartlett

Richard Bartlett is an associate partner at McKinsey & Company in London and a leader in McKinsey’s Medical Products practice and leads McKinsey’s transformation work in Medical Products across Europe. He serves medical product companies on holistics transformation, commercial excellence and strategy predominently in Europe. In addition, Richard serves clients across both the public and private sector in healthcare, focusing on health system strategy and reform, new model of care design, and integrated care.

Paula Bellostas Muguerza

Paula Bellostas Muguerza, principal, Pharmaceutical & Healthcare and Digital Transformation Team, A.T. Kearney. Paula is a member of A.T. Kearney’s global pharmaceutical and healthcare and digital transformation practices. She has consulted for nearly a decade in the pharmaceutical industry, helping pharmaceutical and biopharmaceutical clients formulate strategic responses to changes in the healthcare environment, regularly working with senior management teams. Her current area of interest is understanding the threats and opportunities that digital technologies bring to the pharmaceutical value chain. She has contributed to many industry articles and is a non-executive director for a digital health start-up that focuses on using digital technologies to achieve sustainable human performance.
Outside of A.T. Kearney, Paula is an ambassador for the Samaritans charity working on corporate outreach and is an active blogger on mental health in the workplace.

Richard Blyth

Richard Blyth is Chief Customer Officer at Healthcare at Home, the leading pan-European, insight based Managed Medication Service for complex medicines. He is responsible for Strategy, Insight, Marketing, Sales, Relationships across PharmaCo & the NHS but most importantly the voice of the customer. Richard is redefining Healthcare at Home as a truly customer centric organisation starting with the end to end digitisation of the business.

Richard joined HaH in January 2018 from SAGA, where he created a new domiciliary care division - SAGA Healthcare. As MD he developed a portfolio of blended, technology enabled, ‘At home’ care solutions for seniors. He has particular expertise in articulating and operationalising brand advantage. His integrating approach has driven sales and share growth in previous roles at RBS, NatWest, GE Capital and Santander.

Deborah Evans

Deborah Evans FFRPS FRPharmS FRSPH is managing director of Pharmacy Complete (The Tipping Point Ltd), whose purpose is to help patients to live well for longer by enabling pharmacy to have a healthier future. In pharmacy, our professional credibility, understanding of medicines access, health policy and our extensive professional network ensures that we can engage with the right people, have the conversations that matter and develop solutions that work. We help pharmacy be more successful by supporting business sustainability, training for the pharmacy team, project management, service design and implementation and much more. Deborah led the national, award-winning Healthy Living Pharmacy (HLP) pathfinder work programme on behalf of the national pharmacy bodies and the Department of Health, initially project managing the acclaimed Portsmouth HLP pilot and now offers a complete suite of services and resources to enable pharmacy teams to make a difference to the health and wellbeing of their local population. She is passionate about enabling more women to take senior positions in the pharmacy profession and is founder of the highly successful Women in Pharmacy Facebook community which has 7000 members across the world.

Her professional achievements include being made a Fellow of the Royal Pharmaceutical Society (RPS), serving the RPS English Pharmacy Board, and becoming a Faculty Fellow. She is also visiting senior lecturer at King’s College, London. Deborah feels it is important to keep her pharmacy knowledge up to date and feet firmly planted in the real world so still works regularly in community pharmacy within a GP practice.

Karen Fraser

Karen Fraser is managing director of Acuitas, a consultancy providing astute commercial insight and international KOL perspective to the biopharma and investment communities. She has over 30 years' industry experience, which includes senior sales and marketing positions in companies such as Amersham International, Glaxo Laboratories and Lorex Synthélabo. Karen also set up a successful marketing consultancy specialising in the provision of commercial planning and implementation for companies wishing to enter the UK market. Prior to setting up Acuitas, she spent 15 years as vice president at Quintiles, providing marketing and therapeutic insight to support global Due Diligence and Business Development activities.

Stephanie Hall

Stephanie Hall founded Uptake Strategies in 2005 with a vision to create a completely different kind of healthcare consultancy:  a lean, agile, patient-centric consultancy driving brand performance with measurable business impact setting best practice standards in the industry.  Uptake Strategies is now a multi award winning consultancy and a client base of the world’s top pharma and biotech companies.

Stephanie has been recognized in the UK Business Awards in 2018 for Woman Business Owner of the Year and is an alumni of the Goldman Sachs and University of Oxford 10,000 small businesses entrepreneurs’ programme (2018). Stephanie has been recognized as one of the UK’s top 10 women entrepreneurs in EY’s Winning Women Entrepreneurs’ programme in 2019.

As a chartered  management accountant and a chartered marketer and with a degree in French and Italian, Stephanie brings a unique approach to solving your business challenges. Stephanie has over 25+ years experience in marketing, finance, sales roles and consultancy projects in multi-national pharma/biotech companies (GSK, Eli Lilly & Co, Sanofi) and alliance partnerships.

Stephanie lectures for the Chartered Institute of Marketing (CIM) at Post Graduate level and speaks regularly at industry conferences and is the author of the Pharma Brand Planners’ blog in Pharma Marketing Europe and pmlive.com.

Therapeutic experience spans the major diagnoses e.g. cardiology, respiratory, neuroscience, obesity, oncology, diabetes, rare diseases, dermatology and ADHD.

Stephanie describes herself as strategic, driven, passionate about healthcare marketing and fascinated by new challenges, international cultures and entrepreneurship.

Giorgia Leoni

Giorgia Leoni is one of EY’s Global Commercial Strategy Leaders in Life Sciences. She spent her career in consulting, primarily in pricing and market access strategy, for many years to later focus on business model innovation and outcomes based models. Throughout her career, Giorgia supported top life sciences companies with the launch strategy of their key assets and has recently won the Management Consultancies Association (MCA) Award for best International project for EY’s work with AstraZeneca on their first digital therapeutic.

Giorgia is passionate about the diversity and inclusiveness agenda and held pivotal roles within the Healthcare Businesswomen Association for several years.

Alasdair Mackintosh

Alasdair Mackintosh is director and founder, Keyhaven Associates Ltd. He is a senior business advisor and independent strategy and transformation consultant with extensive experience in the healthcare sector. He is also a Trustee and Vice Chair of the Pituitary Foundation, a patient-focused charity which provides essential information and support for people diagnosed with a range of pituitary disorders.

Over the past 24 years, Alasdair has supported many major healthcare organisations to enhance their commercial performance, develop effective digital strategies, and deliver better health outcomes for patients. He also helps entrepreneurs and investors in smaller, emerging enterprises to assess expansion opportunities, strengthen their business processes and governance, and to build effective organisations.

Alasdair was previously a partner and member of the global leadership teams at PA, Eden McCallum, Archstone and Gemini Consulting. He has an MSc in Business Management from the University of London and is a Sloan Fellow of the London Business School.

Thalita Marinho

Thalita Marinho is a Director in the Strategy Team of PricewaterhouseCoopers. She has 14 years of industry and consulting experience in the pharmaceutical and energy sectors. She worked at Royal Dutch Shell in Strategy and Economic valuation roles. She then joined Booz & Company, a strategic management consultancy, where she focused on commercial strategy in the Pharma and Life sciences sector.

At PwC, Thalita works closely with global pharma leaders to develop and implement corporate and business level strategy. She leads projects on topics across the pharma value chain, including Sale & Marketing, Market Access & Pricing, and Patient Centricity. Her clients include Big Pharma, biotechs, generics, OTC and healthcare distributors.

Thalita has an MBA from the London Business School and is an Economist.

Craig Mills

Craig Mills is Founder, of Frontera Group. He is the Group’s Head of Strategy with over 20 years’ experience in the healthcare sector. Craig is a judge and business leader on the entrepreneurship programme, Bright Ideas at Kingston University, London. He is also an active supporter of the Pathway - the Faculty for Homeless and Inclusion Health, which seeks to transform health outcomes for one of societies most deprived groups.

Over the past 20+ years, Craig has led healthcare organisations driving their commercial performance, by helping them to develop strategies that centre on the patient’s experience of health. Today he runs a group of 3 agencies focused on the acquisition of real world evidence and, in partnership with academic teams, including Imperial College and University of Cambridge, supporting organisations in the adoption of behavioural theory to bring about the change they seek.

Rachael Scott

Rachael Scott is a partner leading the UK Health and Lifesciences Practice at PA Consulting.  Rachael specialises in operational and commercial improvement, leading cross functional programmes in both Biotech and large Pharma with a focus on what it really takes to make change stick. She has a passion for working with organisations that look to challenge their selves and face the disruption in the market place head on.

Paul Simpson

Paul Simpson is the Head of Contract Sales and Medical Solutions at IQVIA UK.

He has extensive pan-European and US experience of pharma/biotech commercialisation and has held senior roles in marketing, sales and general management.

Paul is a staunch advocate of account management, using environmental understanding to derive practical solutions which help clients drive healthcare forward and ultimately lead to better outcomes for patients.

Professor Brian D Smith

Professor Brian D Smith is an academic, author and advisor who has worked in the industry since 1978. He researches the evolution of the life sciences industry at both Bocconi and Hertfordshire Universities and has published 300 papers, books and articles about strategy in the industry, including The Future of Pharma, Darwin’s Medicine, Brand Therapy and, most recently, Leadership in the Life Sciences. As Principal Advisor of Pragmedic Limited, he advises many of the industry’s leading companies about how to adapt competitive capabilities to changing market conditions.

Dr Paul Stuart-Kregor

Dr Paul Stuart-Kregor is one of the three founders of The CELLO Health Consultancy and has worked in pharmaceuticals for 30 years, both client side and consultancy.

Paul has wide-ranging pharmaceutical, OTC and consumer marketing experience in UK and overseas, with expertise focused in the areas of market scoping and market insight for new and existing therapy areas, marketing strategy (Phase II to in-market compounds), brand development/repositioning, organisational design and process development plus marketing and operational excellence.

His focus now also includes mentoring future business leaders and working with start ups.

He holds an MA from Cambridge University and a PhD in Reproductive Endocrinology. He has been extensively published across a range of industry journals.

Sponsors

Key dates

Entry deadline 27 August 2020
Extended entry deadline 3 September 2020*
*additional fee applies
Judging Day 1 October 2020
Company of the Year Interviews 22 October 2020
PMEA Event 25 November 2020